1. Home
  2. CME vs BSX Comparison

CME vs BSX Comparison

Compare CME & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CME Group Inc.

CME

CME Group Inc.

HOLD

Current Price

$307.67

Market Cap

106.9B

Sector

Finance

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$69.74

Market Cap

103.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CME
BSX
Founded
1898
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.9B
103.6B
IPO Year
2002
2010

Fundamental Metrics

Financial Performance
Metric
CME
BSX
Price
$307.67
$69.74
Analyst Decision
Buy
Strong Buy
Analyst Count
14
20
Target Price
$295.62
$106.85
AVG Volume (30 Days)
2.1M
10.7M
Earning Date
04-22-2026
04-22-2026
Dividend Yield
3.69%
N/A
EPS Growth
15.41
55.20
EPS
11.16
1.94
Revenue
$6,520,600,000.00
$9,076,000,000.00
Revenue This Year
$8.62
$12.02
Revenue Next Year
$4.64
$10.41
P/E Ratio
$27.56
$35.95
Revenue Growth
6.37
12.49
52 Week Low
$248.63
$67.56
52 Week High
$329.16
$109.50

Technical Indicators

Market Signals
Indicator
CME
BSX
Relative Strength Index (RSI) 48.80 35.16
Support Level $261.65 $67.56
Resistance Level $309.35 $76.77
Average True Range (ATR) 5.38 1.76
MACD -1.90 0.44
Stochastic Oscillator 27.52 35.10

Price Performance

Historical Comparison
CME
BSX

About CME CME Group Inc.

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: